Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1897 1
1898 1
1928 2
1934 1
1935 1
1938 1
1940 1
1945 30
1946 88
1947 97
1948 118
1949 119
1950 130
1951 207
1952 213
1953 230
1954 234
1955 253
1956 206
1957 254
1958 237
1959 225
1960 256
1961 304
1962 301
1963 457
1964 570
1965 361
1966 363
1967 441
1968 443
1969 504
1970 466
1971 533
1972 511
1973 467
1974 527
1975 546
1976 525
1977 550
1978 580
1979 687
1980 631
1981 766
1982 820
1983 900
1984 1032
1985 1143
1986 1086
1987 1126
1988 1205
1989 1458
1990 1496
1991 1344
1992 1563
1993 1810
1994 1847
1995 1814
1996 1881
1997 1957
1998 1985
1999 2104
2000 2241
2001 2367
2002 2383
2003 2656
2004 2880
2005 3015
2006 3325
2007 3449
2008 3510
2009 3846
2010 4075
2011 4445
2012 4805
2013 4977
2014 5390
2015 5707
2016 5788
2017 5781
2018 5866
2019 6425
2020 7218
2021 7503
2022 7201
2023 6812
2024 7101
2025 1877

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148,464 results

Results by year

Filters applied: . Clear all
Page 1
Ovarian Cancer: An Overview.
Penny SM. Penny SM. Radiol Technol. 2020 Jul;91(6):561-575. Radiol Technol. 2020. PMID: 32606233 Review.
Ovarian cancer currently is the fifth leading cause of cancer-related deaths among women in the United States, and approximately 140 000 women die globally per year of ovarian cancer. ...To provide care that is most favorable for the patient, he …
Ovarian cancer currently is the fifth leading cause of cancer-related deaths among women in the United States, and appr …
Ovarian Cancer: An Integrated Review.
Stewart C, Ralyea C, Lockwood S. Stewart C, et al. Semin Oncol Nurs. 2019 Apr;35(2):151-156. doi: 10.1016/j.soncn.2019.02.001. Epub 2019 Mar 11. Semin Oncol Nurs. 2019. PMID: 30867104 Review.
CONCLUSION: There is no screening test for ovarian cancer and with diagnosis often in the late stages, recurrence is high in this population. ...Although advances are being made, ovarian cancer remains the most fatal female gynecologic cancer. I …
CONCLUSION: There is no screening test for ovarian cancer and with diagnosis often in the late stages, recurrence is high in t …
Ovarian cancer.
Cho KR, Shih IeM. Cho KR, et al. Annu Rev Pathol. 2009;4:287-313. doi: 10.1146/annurev.pathol.4.110807.092246. Annu Rev Pathol. 2009. PMID: 18842102 Free PMC article. Review.
Moreover, within the most common histological types, the molecular pathogenesis of low-grade versus high-grade tumors appears to be largely distinct. Mouse models of ovarian carcinoma have been developed that recapitulate many of the morphological features, biological beha …
Moreover, within the most common histological types, the molecular pathogenesis of low-grade versus high-grade tumors appears to be largely …
Clinical and translational advances in ovarian cancer therapy.
Konstantinopoulos PA, Matulonis UA. Konstantinopoulos PA, et al. Nat Cancer. 2023 Sep;4(9):1239-1257. doi: 10.1038/s43018-023-00617-9. Epub 2023 Aug 31. Nat Cancer. 2023. PMID: 37653142 Review.
Ovarian cancer is an aggressive disease that is frequently detected at advanced stages and is initially very responsive to platinum-based chemotherapy. ...In this Review, we outline the main therapeutic principles behind the management of newly diagnosed and recurre …
Ovarian cancer is an aggressive disease that is frequently detected at advanced stages and is initially very responsive to pla …
Ovarian cancer: an overview.
Roett MA, Evans P. Roett MA, et al. Am Fam Physician. 2009 Sep 15;80(6):609-16. Am Fam Physician. 2009. PMID: 19817326 Free article. Review.
Although ovarian cancer may occur at any age, it is more common in patients older than 50 years. ...Epithelial ovarian cancer is the most common type of ovarian cancer, and because 70 percent of cases are diagnosed at stage III or IV, it …
Although ovarian cancer may occur at any age, it is more common in patients older than 50 years. ...Epithelial ovarian …
Epidemiology of epithelial ovarian cancer.
Webb PM, Jordan SJ. Webb PM, et al. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:3-14. doi: 10.1016/j.bpobgyn.2016.08.006. Epub 2016 Oct 3. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 27743768 Review.
Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. ...In this paper we will summarise the current state of knowledge regarding the known and pos …
Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer d …
Clinical Staging of Ovarian Cancer.
O'Shea AS. O'Shea AS. Methods Mol Biol. 2022;2424:3-10. doi: 10.1007/978-1-0716-1956-8_1. Methods Mol Biol. 2022. PMID: 34918284
The clinical management and prognosis of ovarian cancer depend upon the stage of the cancer. Cancer stage is the extent to which the cancer has spread from its site of origin. ...In more advanced cases, this surgery may also include procedures t …
The clinical management and prognosis of ovarian cancer depend upon the stage of the cancer. Cancer stage is the …
Ovarian Cancer: A Heterogeneous Disease.
Kossaï M, Leary A, Scoazec JY, Genestie C. Kossaï M, et al. Pathobiology. 2018;85(1-2):41-49. doi: 10.1159/000479006. Epub 2017 Oct 12. Pathobiology. 2018. PMID: 29020678
Ovarian cancer encompasses a collection of neoplasms with distinct clinicopathological and molecular features and prognosis. Despite there being a variety of ovarian cancer subtypes, these are treated as a single disease. Tremendous efforts have …
Ovarian cancer encompasses a collection of neoplasms with distinct clinicopathological and molecular features and progn …
Ovarian Cancer Prevention and Screening.
Menon U, Karpinskyj C, Gentry-Maharaj A. Menon U, et al. Obstet Gynecol. 2018 May;131(5):909-927. doi: 10.1097/AOG.0000000000002580. Obstet Gynecol. 2018. PMID: 29630008 Review.
There has been much progress in ovarian cancer screening and prevention in recent years. Improved tools that combine genetic and epidemiologic factors to predict an individual's ovarian cancer risk are set to become available for tailoring preventive a …
There has been much progress in ovarian cancer screening and prevention in recent years. Improved tools that combine genetic a …
Real-world evidence in the treatment of ovarian cancer.
Eisenhauer EA. Eisenhauer EA. Ann Oncol. 2017 Nov 1;28(suppl_8):viii61-viii65. doi: 10.1093/annonc/mdx443. Ann Oncol. 2017. PMID: 29232466 Free article. Review.
This paper reviews RWE on the impact of treatment in ovarian cancer. MATERIALS AND METHODS: A literature review of publications addressing population level survival outcomes of new surgical and systemic treatment interventions in ovarian cancer was und …
This paper reviews RWE on the impact of treatment in ovarian cancer. MATERIALS AND METHODS: A literature review of publication …
148,464 results
You have reached the last available page of results. Please see the User Guide for more information.